CLINICAL AND PATHOGENETIC ASPECTS OF ISCHAEMIC HEART DISEASE COMPLICATED BY CHTONIC HEART FAILURE
Author(s) -
Н. П. Дорофеева,
С А Плескачев,
С. В. Шлык,
E V Tchigaeva,
E A TherAnanyanz,
О Г Машталова,
I E Koulikova,
А С Плескачев,
С. С. Тодоров
Publication year - 2011
Publication title -
journal of clinical practice
Language(s) - English
Resource type - Journals
eISSN - 2618-8627
pISSN - 2220-3095
DOI - 10.17816/clinpract2167-73
Subject(s) - heart failure , decompensation , medicine , cardiology , aldosterone , ischaemic heart disease , genotyping , renin–angiotensin system , myocardial infarction , disease , gene , genotype , blood pressure , biology , biochemistry
Objectives: To investigate genetic and neurohumoral determinants of chronic heart failure (CHF) development and progression in ischaemic heart disease (IHD) patients. Methods: Serum neurohormone level analysis (angiotensin II, aldosterone, endotheline1, NTproBNP, TNFα) and genotyping (genes encoding ACE, angiotensinogen, and type1 angiotensin II receptors ) were implemented in 100 patients Results: Activation of endotheline and NTproBNP is characteristic of early CHF stages while decompensation of chronic heart failure shows elevation in aldosterone and TNFα . Structural polymorphism of renineangiotensine system genes is not significant in CHF development and progression in IHD patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom